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h i g h l i g h t s
• Cortical spreading depression (CSD) likely underlies migraine aura.
• Periaqueductal gray matter (PAG) controls pain and autonomic functions.
• CSD provocation decreased neuronal Fos in PAG and Edinger–Westphal nucleus of rats.
• The numbers of CSDs correlated negatively with Fos-immunoreactive counts.
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a b s t r a c t
The migraine headache involves activation and central sensitization of the trigeminovascular pain path-
way. The migraine aura is likely due to cortical spreading depression (CSD), a propagating wave of brief
neuronal depolarization followed by prolonged inhibition. The precise link between CSD and headache
remains controversial. Our objectives were to study the effect of CSD on neuronal activation in the peri-
aqueductal greymatter (PAG), an area known to control pain and autonomic functions, and to be involved
inmigrainepathogenesis. Fos-immunoreactivenucleiwere counted in rostral PAGandEdinger–Westphal
nuclei (PAG–EWn bregma −6.5mm), and caudal PAG (bregma −8mm) of 17 adult male Sprague–Dawley
rats after KCl-induced CSD under chloral hydrate anesthesia. Being part of a pharmacological study,
six animals had received, for the preceding 4 weeks daily, intraperitoneal injections of lamotrigine
(15mg/kg), six others had been treated with saline, while ﬁve sham-operated animals served as controls.
We found that the number of Fos-immunoreactive nuclei in the PAG decreased after CSD provocation.
Therewas nodifference between lamotrigine- and saline-treated animals. The number of CSDs correlated
negatively with Fos-immunoreactive counts. CSD-linked inhibition of neuronal activity in the PAG might
play a role in central sensitization during migraine attacks and contribute to a better understanding of
the link between the aura and the headache.
© 2014 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
In about 20% of subjects, the migraine headache is preceded
by neurological aura symptoms [42]. Cortical spreading depression
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(CSD) is thought to be the underlying mechanism of the migraine
aura [19]. The migraine headache involves activation and central
sensitization of the trigeminovascular pain pathway. The precise
link between CSD and headache remains controversial [18], as does
the possibility that CSD-like events may also occur during attacks
of migraine without aura [49].
In rat CSD can activate second order trigeminovascular projec-
tions of the spinal trigeminal nucleus [23] and provoke behavioral
changes comparable to those seen during the migraine attack [2].
Migraine attacks are associated with activation in an upper brain
http://dx.doi.org/10.1016/j.neulet.2014.11.026
0304-3940/© 2014 Elsevier Ireland Ltd. All rights reserved.
V. Borysovych Bogdanov et al. / Neuroscience Letters 585 (2015) 138–143 139
stem area that includes periaqueductal grey matter (PAG) [1]. On
magnetic resonance imaging (MRI), iron deposition [47], and tis-
sue density [41] were found increased in the PAG of episodic
and chronic migraine patients. Lesions in the PAG can provoke
migraine-like headaches [17] as can electrodes implanted for neu-
rostimulation therapy of chronic pain [40]. In functional MRI
studies the connectivity of the PAG in migraine patients was
increased with somatosensory and nociceptive circuits which cor-
related with disease duration [33]. Speciﬁc anti-migraine drugs,
like triptans, when injected in the PAG of experimental animals,
are able to inhibit trigeminal nociceptor responses inducedbydural
stimulation [4].
The PAG is a pivotal component of the descending pain
inhibitory system but also of emotional behavior and autonomic
control [5]. It receives afferents from the cortex [46], where CSD
occurs [19], and projects to hypothalamus [46], and raphe nuclei
[5] thought to be involved in migraine pathogenesis. Neuronal dys-
function in the PAG may, thus, be involved in various features that
accompany the migraine attack [30].
We hypothesized that CSD would be able to modify neuronal
activity in the PAG. Fos expression, a validated marker of neuronal
activation, was used to estimate activity of PAG neurons after arti-
ﬁcial provocation of CSDs over the occipital cortex of anesthetized
rats. Since we previously shown that lamotrigine (LTG) is a potent
inhibitor of KCl-induced CSD in rat cerebral cortex [6], we included
LTG-treated animals in that study to verify if pharmacological sup-
pression of CSDs abolishes the effect of CSDs on PAG.
2. Methods
2.1. Experimental animals
Seventeenadultmale Sprague–Dawley ratswere randomly cho-
sen among those used in a previously published study on the effect
of preventive anti-migraine drugs on CSD [6]. The animals weighed
between 300g and 480g on the day of recordings. All animals were
separated randomly onto three experimental groups during the
therapeutic study [6]. Five rats were sham-operated and received
no treatment. Two groups of six animals received, for 4weeks daily,
intraperitoneal (IP) injections of saline or lamotrigine (15mg/kg, a
gift by GSK, UK). The number of animals used was kept to a min-
imum and chosen according to the numbers used in other c-Fos
studies in PAG [22]. The Ethics Committee of University of Liege
approved the study and the guidelines for animal care were fol-
lowed.
2.2. Anesthesia and surgery
Anesthesia was induced by 400mg/kg chloral hydrate (8% in
saline, 5ml/kg) and maintained by smaller doses (80mg/kg) added
every hour. Level of anesthesia was monitored by tail pinch and
electrocorticogram (ECoG) where applicable. Rectal temperature
was maintained between 36.5 and 37.0 ◦C using a thermostatically
controlled heating blanket (ATC 1000®, WPI Inc., USA). The rats
were placed in a stereotaxic frame (David Kopf Instruments, USA).
Three 1–2mm wide burr holes were drilled 2mm off the midline:
7mm posterior to bregma (P-7; occipital cortex; stimulation site),
4mm posterior to bregma (P-4; occipito–parietal junction; poste-
rior recording site), and 1mm anterior to bregma (A+1; frontal
cortex; anterior recording site) [39] to observe the propagation of
CSD which was the aim of main study.
2.3. CSD provocation and recordings
The detailed stimulation and recording procedures were
described previously [6]. Brieﬂy, after surgery that lasted
30–40min, in all animals except in the sham-operated group, we
induced CSD with a cotton ball soaked with 1M KCl placed over
the occipital cortex (AP-7, R +2). The cotton ball was kept moist by
adding every 20min a 1.5l drop of KCl and left in place for 2h. For
sham-operated animals the cotton ball was soaked with artiﬁcial
CSF. CSDs and the electrocorticogram (DC-100Hz) were recorded
ipsilaterally from two cortical areas: frontal (bregma AP+1, R +2)
andoccipito-parietal (AP -4, R +2) at a depth of 1±0.2mm.Animals
were sacriﬁced immediately after the recordings, i.e., on average
2h 30min after induction of the ﬁrst CSD by an IP nembutal injec-
tion (natrium pentobarbital 60mg/ml:3ml/kg BW according to the
ethical guidelines of the University of Liege).
2.4. Histology
Rats were perfusion-ﬁxed with 500ml 4% paraformaldehyde in
phosphate-buffered saline. After cryoprotection (30% sucrose for
two days), 30m transverse serial cryostat sections of the brain
were cut and serially collected in 12 wells containing cold PBS.
Each well received sections at a 360m distance throughout the
rostro-caudal extentof thebrain. Fos expressionwasassessedusing
standard immunohistochemistry protocol [8]. Free-ﬂoating sec-
tions after pretreatment were kept overnight at room temperature
in anti-c-Fos (Santa Cruz Biotechnology, sc-52-G) primary anti-
serum at a dilution of 1:1500. The immunocytochemical reaction
product was visualized using the Vectastain (Vector Laboratories,
Inc., PK-6101) avidin–biotin kit (ABC) with imidazole-intensiﬁed
3,3′-diaminobenzidine. Running during each staining procedure a
series of sections without the primary antiserum served to control
speciﬁcity of immunoreactivity.
Fos-immunoreactive (Fos-Ir) nuclei were counted automati-
cally on a digital image analyzer in 2000×2000m areas of
interest manually adjusted. The software package analySIS (Olym-
pus soft imaging solutions GmbH) was used for the automatic
counting. Counts were performed on three sections separated
by 360m at two PAG levels: (1) PAG, bregma −8mm or (2)
PAG+Edinger–Westphal nucleus (EWn), bregma −6,5mm [39].
As the PAG comprises different functional segments, we sepa-
ratelyquantiﬁedFosexpression inventro-lateral, dorso-lateral, and
dorso-medial segments of the rostral PAG area and EWn (bregma
−6.5mm). For every image the aqueductwas located;we corrected
rotation of sections according to the shape of the aqueduct. The
periaqueductal area was then subdivided into six radial segments,
as shown in Fig. 1 (top panel). The number of Fos-Ir particles was
estimated separately for each of functional segments.
2.5. Statistical analyses
Statistica 9.0 (StatSoft Inc., Tulsa, OK, USA) was used for the
statistical analysis. Group values were expressed as means±95%
conﬁdence intervals. The unit of analysis was a count of Fos-Ir in
a single slice for histology and an animal for occurrence of elec-
trophysiologically recorded CSDs during 2h. Shapiro–Wilk test for
normality used for each group separately did not detect violation
of normal distribution of the dependent variables;we relied, there-
fore, on parametric statistics.
We used repeated measures two-way ANOVA to test for the
group differences in Fos-Ir expression. Where ANOVA revealed a
signiﬁcant between-group difference, we used post-hoc Scheffe’s
test for pair-wise comparison of the group means.
Spearman’s rank order correlations (R) where computed in each
CSD group to explore the links between the number of CSDs and of
Fos-Ir nuclei in individual animals.
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Fig. 1. Top: scheme of segmentation into dorso-medial PAG, dorso-lateral PAG, and
ventro-lateral PAG (periaqueductal gray matter) segments and Edinger–Westphal
nucleus, EWn/3N areas on a Fos-Ir transverse section of the region of interest
(bregma −6.5mm). Bottom: illustrative camera lucida drawings of Fos-Ir nuclei
identiﬁed in transverse sections of rostral (bregma −6.5mm) and caudal parts
(bregma −8mm) of the PAG in an animal belonging to the sham-operated, CSD-
stimulated and NaCl-treated, or CSD-stimulated and lamotrigine (LTG)-treated
groups. Three sections separated by 360m are shown for the two PAG levels.
3. Results
3.1. CSD numbers
The results on CSD numbers and propagation were reported
and discussed previously [6] and will not be described in
detail here. Brieﬂy, in lamotrigine treated group frequencies of
occipito–parietal and frontal CSDs (4.4±3.1 and 1.6±0.8, respec-
tively) were signiﬁcantly reduced comparatively to saline treated
animals (6.7±0.9 and 3.4±0.8, respectively).
3.2. Numbers of Fos-Ir neurons in PAG and EWn
There was no difference in Fos-Ir between right and left PAG in
any animal group (Fig. 1, bottom panel). ANOVA showed between-
group differences for both rostral (p<0.001) and caudal (p<0.001)
PAG areas. CSD provocation resulted in reduction in the number of
Fos-positive cells both in the rostral PAG+EWn area and in the cau-
dal PAG area in animals treated either with NaCl (respectively, 53%
and 61% decrease, p<0.01) or lamotrigine (respectively, 68% and
73% decrease, p<0.001), as compared to animals that underwent
sham craniotomy and anesthesia of equivalent duration (Fig. 2, top
panel). The difference between NaCl- and lamotrigine-treated rats
was not signiﬁcant.
When we analyzed counts of Fos-Ir nuclei separately in dorso-
medial, dorso-lateral, and ventro-lateral segments of the PAG, the
between-groupdifferenceswere similar to those found for the total
PAGarea (Table1). BothNaCl and lamotriginegroupshaddecreased
Fos-Ir expression in all PAG segments compared to the sham group
with a trend towards the least Fos expression in the lamotrigine
group. In the EWn segment, the difference in Fos expression was
signiﬁcant only between shamand lamotrigine groups,whileNaCl-
treated animals had an intermediate level of Fos-Ir nuclei.
3.3. Correlation between PAG and EWn Fos-Ir neuron counts and
CSD numbers
Using Spearman’s rank correlation test, the number of Fos-
Ir nuclei in the PAG overall correlated negatively with that of
CSDs. In lamotrigine-treated animals, in particular, there was a
signiﬁcant inverse correlation between Fos-Ir expression in both
rostral and caudal PAG areas and number of occipito–parietal
CSDs (R=−0.82, p=0.05, and −0.84, p=0.036, respectively) (Fig. 2,
bottom panel). Fos-Ir in the EWn segment tended strongly to cor-
relate negatively with number of frontal CSDs in the NaCl-treated
group (R=−0.79, p=0.059) and with occipito-parietal CSDs in the
lamotrigine-treated group (R=−0.75, p=0.084). In the global ros-
tral PAG/EWn area we found the same inverse correlation with
a strong trend for signiﬁcance between number of Fos-Ir nuclei
and frontal CSDs in NaCl-treated rats (R=−0.79, p=0.059) (Fig. 2,
bottom panel).
4. Discussion
This study shows that waves of CSDs induced by unilateral KCl
application on the occipital cortex result in a reduction of the
number of Fos-positive cells in the PAG of anesthetized rats. The
reduction is proportional to the number of induced CSDs, and thus,
not due to KCl itself; it is not found in sham-operated animals.
The neuronal inactivation in PAG is likely due to the CSD-
induced changes in cortical activity. Whether activation of
inhibitory cortical projections to the PAG by the initial depolariza-
tion associated with CSDs or inactivation of excitatory projections
during the subsequent prolonged neuronal inhibition is the culprit
cannot be determined here. Given, however, that most known pro-
jections from cortical areas to the PAG are excitatory [10,15,27,38]
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Fig. 2. Top: histogram of the number (mean±95% conﬁdence intervals) of Fos-immunoreactive (Fos-Ir) nuclei in sham-operated animals (n=5), in animals that had CSDs
induced and were treated preventively either with NaCl (n=6) or with lamotrigine (LTG-15mg/kg; n=6). Upper left panel: rostral PAG–Ewn portion (bregma −6.5mm).
Upper right panel: caudal PAG portion (bregma −8mm). ANOVA group difference (p<0.001) both for rostral PAG+EWn and caudal PAG. Scheffe’s post-hoc test: *p<0.01,
**p<0.001, compared to the sham-operated group. Bottom: scatterplots of the number of Fos-Ir nuclei (ordinate) and the number of CSDs per hour showing the negative
correlation between the two. Left panel: frontal CSDs and rostral PAG Fos-Ir nuclei in NaCl-treated animals. Middle panel: occipito–parietal CSDs and rostral PAG Fos-Ir nuclei
in LTG-treated animals. Right panel: occipito–parietal CSDs and caudal PAG Fos-Ir nuclei in LTG-treated animals.
decreased excitation of PAG neurons during the depression phase
of CSDs is a plausible explanation. The observed bilateral reduc-
tion in Fos-Ir PAG neurons, despite unilateral CSDs, and unilateral
cortical Fos activation [6], can be due to the fact that projections
from the cerebral cortex to the PAGare both ipsi- and contra-lateral
[15].
We cannot exclude the possibility that subcortical areas in part
mediate the CSD-induced reduction of neuronal activity in PAG.
CSD can indeed propagate to the amygdala where it signiﬁcantly
augments long-term potentiation [13]. The central nucleus of the
amygdala has both excitatory and inhibitory connections with
ventro-lateral PAG [11], an area receiving also projections from
the trigeminal nucleus. Freezing induced by CSDs in awake rats
has been attributed to synergic amygdala–PAG activity [2]. Another
area projecting to PAG is the hypothalamus [5] and CSDs increase
Fos expression bilaterally in the magnocellular part of hypothala-
mic paraventricular nulei while decreasing it in the parvocellular
portion [24]. Interestingly, the early premonitory phase ofmigraine
attacks is associated with activation of the hypothalamus in addi-
tion to midbrain and pons [34].
Our ﬁndings are in line with those of Lambert et al, [30] show-
ing in cat CSDs or ﬂashing light stimulation, both considered to be
migraine triggers, reduce the inhibition of second order trigemino-
vascular neurons induced by PAG stimulation (unpublished results
[30]), and inhibit neurons in nucleus raphe magnus [29].
Suppression of PAG also might play a role in the cutaneous allo-
dynia that frequently accompanies migraine attacks and predicts
migraine chroniﬁcation [32]. Migraineurs with severe allodynia
have stronger functional connectivity between PAG and other
cerebral areas involved in pain processing [32] while descending
Table 1
Number of Fos-immunoreactive cells (means±95% conﬁdence intervals) in the different segments of the rostral PAG/EWn area at bregma −6.5mm in sham-operated animals
and in animals that had CSDs induced for 2h after a preventive daily treatment for 1 month with NaCl or lamotrigine (LTG, 15mg/kg).
Sham surgery (n=5) NaCl treatment (n=6) LTG treatment (n=6) ANOVA group effect, p
Dorso-medial PAG 34 ± 8 14 ± 8* 7 ± 8** 0.001
Dorso-lateral PAG 56 ± 16 15 ± 15* 13 ± 15* 0.001
Ventro-lateral PAG 67 ± 17 23 ± 15* 16 ± 15* 0.001
EWn 83 ± 15 59 ± 13 41 ± 13* 0.002
* −0.01.
** −0.001; for post-hoc Scheffe’s test, in comparison to the sham-surgery group.
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analgesia areas are disconnected from PAG in patients with allo-
dynia [33].
PAG inhibition might also be responsible for other migraine
symptoms. Besides increasing perception of any pain stimulus,
e.g., that coming from neurogenic inﬂammation [36], it could be
involved in the behavioral and autonomic symptoms that accom-
pany themigraine attack, as such functions are in part controlled by
the ventro-lateral PAG [9] in particular freezing/quiescence, nau-
sea, localized hyperalgesia during noxious stimulation, emotional
irritability, and aggressive behavior [3].
The inhibitory effect of CSDs was not limited to the PAG, but
extended to the Edinger–Westphal nucleus (EWn). The EWn is
thought to be composed of at least two neuronal populations
[44]. The cholinergic neurons of the preganglionic parasympathetic
population innervate the pupillary constrictor and the ciliary mus-
cles [16]. The second population of neurons uses peptides, such
as urocortin-1 [45] and amphetamine-regulated transcript (CART)
[14], as neurotransmitters and seems to be implicated in stress
response and feeding behavior [28,43,48]. It remains to be deter-
minedwhether the inhibition of these twoneuronal populations by
CSDs associated with the migraine aura could be implicated in the
behavioral changes, nutritional disturbances, and pupillary abnor-
malities [12,20] that can be associated with the migraine attack.
There are no known direct cortical projections to the
Edinger–Westphal nuclei. These nuclei receive projections from
rostral PAG [26] andproject reciprocally to all PAG columns that are
themselves bilaterally interconnected [25]. In functional studies,
however, the cerebral cortex is able to modulate pupil size via the
Edinger–Westphal nuclei [21]. Transcranial magnetic activation of
frontal, central, and parieto–occipital areas, for instance, produces
dilatation of both pupils that is maximal after ±1.5 s [37]. There-
fore, CSD-induced inhibition of EWn activity might be involved in
the mydriasis accompanying certain migraine attacks.
Wehave previously shown that lamotrigine signiﬁcantly lowers
CSD frequency [6] and we expected, therefore, to ﬁnd more Fos-Ir
PAG neurons in lamotrigine-treated than in saline-treated animals.
Surprisingly, there was, however, a similar decrease of Fos expres-
sion in both animal groups. A possible explanation for this ﬁnding
is the fact that lamotrigine is known to block Ca2+ channels in PAG
neurons [35]. This might decrease neuronal activity to a sufﬁcient
extent as to mask the potential increase of Fos expression related
to the lamotrigine-induced reduction of CSD frequency.
5. Conclusion
Cortical spreading depressions, known to cause the aura symp-
toms of migraine, signiﬁcantly decrease neuronal activity in the
periaqueductal grey matter and Edinger–Westphal nucleus as
assessed with Fos immunoreactivity in rats. In a translational
perspective, CSD-induced reduction of neuronal activation in the
pain-controlling upper brainstem centers during themigraine aura
might disinhibit second order neurons in the trigemino-cervical
complex, and thus, promote sensitization and headache.
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